Items without sitelinks

Showing below up to 50 results in range #16,601 to #16,650.

16601. Exposure to or harmful effects of undetermined intent of topical corticosteroid preparations (Q96209)
16602. Exposure to or harmful effects of undetermined intent of antipruritics (Q96208)
16603. Exposure to or harmful effects of undetermined intent of other dental drugs, topically applied (Q96207)
16604. Exposure to or harmful effects of undetermined intent of digestants (Q96206)
16605. Exposure to or harmful effects of undetermined intent of other local astringents or local detergents (Q96205)
16606. Exposure to or harmful effects of undetermined intent of fluoride preparations (Q96204)
16607. Exposure to or harmful effects of undetermined intent of keratolytics, keratoplastics, or other hair treatment drugs or preparations (Q96203)
16608. Exposure to or harmful effects of undetermined intent of emollients, demulcents or protectants (Q96202)
16609. Exposure to or harmful effects of undetermined intent of ophthalmological drugs or preparations (Q96201)
16610. Exposure to or harmful effects of undetermined intent of calcium-channel blockers (Q96200)
16611. Exposure to or harmful effects of undetermined intent of otorhinolaryngological drugs or preparations (Q96199)
16612. Exposure to or harmful effects of undetermined intent of other laxatives (Q96198)
16613. Exposure to or harmful effects of iodine, antiseptic, undetermined intent (Q96197)
16614. Exposure to or harmful effects of undetermined intent of terbutaline (Q96196)
16615. Exposure to or harmful effects of undetermined intent of unspecified drugs acting on muscles (Q96195)
16616. Exposure to or harmful effects of undetermined intent of other anti-common-cold drugs (Q96194)
16617. Exposure to or harmful effects of undetermined intent of antitussives (Q96193)
16618. Exposure to or harmful effects of undetermined intent of aminophylline, theophylline (Q96192)
16619. Exposure to or harmful effects of undetermined intent of oxytocic drugs (Q96191)
16620. Exposure to or harmful effects of undetermined intent of histamine H2-receptor blockers (Q96190)
16621. Exposure to or harmful effects of undetermined intent of other hormones or synthetic substitutes (Q96189)
16622. Exposure to or harmful effects of undetermined intent of other hormone antagonists (Q96188)
16623. Exposure to or harmful effects of undetermined intent of other antacids or anti-gastric-secretion drugs (Q96187)
16624. Exposure to or harmful effects of undetermined intent of salbutamol (Q96186)
16625. Exposure to or harmful effects of undetermined intent of saline or osmotic laxatives (Q96185)
16626. Exposure to or harmful effects of undetermined intent of skeletal muscle relaxants (Q96184)
16627. Exposure to or harmful effects of undetermined intent of expectorants (Q96183)
16628. Exposure to or harmful effects of undetermined intent of stimulant laxatives (Q96182)
16629. Exposure to or harmful effects of undetermined intent of antiasthmatics, not elsewhere classified (Q96181)
16630. Exposure to or harmful effects of undetermined intent of unspecified hormone antagonists (Q96180)
16631. Exposure to or harmful effects of undetermined intent of other drugs acting on muscles (Q96179)
16632. Exposure to or harmful effects of undetermined intent of anterior pituitary hormones (Q96178)
16633. Exposure to or harmful effects of undetermined intent of insulin or oral hypoglycaemic drugs (Q96177)
16634. Exposure to or harmful effects of undetermined intent of androgens or anabolic congeners (Q96176)
16635. Exposure to or harmful effects of undetermined intent of other estrogens or progestogens (Q96175)
16636. Exposure to or harmful effects of undetermined intent of vitamin B12, folic acid or other anti-megaloblastic-anaemia preparations (Q96174)
16637. Exposure to or harmful effects of undetermined intent of natural blood or blood products (Q96173)
16638. Exposure to or harmful effects of undetermined intent of other primarily systemic agents, not elsewhere classified (Q96172)
16639. Exposure to or harmful effects of undetermined intent of oral contraceptives (Q96171)
16640. Exposure to or harmful effects of undetermined intent of thyroid hormones or substitutes (Q96170)
16641. Exposure to or harmful effects of undetermined intent of plasma substitutes (Q96169)
16642. Exposure to or harmful effects of undetermined intent of thrombolytic drug (Q96168)
16643. Exposure to or harmful effects of undetermined intent of anticoagulant antagonists, vitamin K or other coagulants (Q96167)
16644. Exposure to or harmful effects of undetermined intent of acidifying or alkalising agents (Q96166)
16645. Exposure to or harmful effects of undetermined intent of iron or its compounds (Q96165)
16646. Exposure to or harmful effects of undetermined intent of antithrombotic drugs (Q96164)
16647. Exposure to or harmful effects of undetermined intent of other fibrinolysis-affecting drugs (Q96163)
16648. Exposure to or harmful effects of undetermined intent of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified (Q96162)
16649. Exposure to or harmful effects of undetermined intent of unspecified hormones or synthetic substitutes (Q96161)
16650. Exposure to or harmful effects of undetermined intent of anticoagulants (Q96160)